Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes

Experimental Cell Research

Volumn 312, Issue 10, 2006, Pages 1745-1752

  Mourtada Maarabouni, Mirna ^a   Keen, Jennifer ^a   Clark, Jeremy ^b   Cooper, Colin S ^b   Williams, Gwyn T ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

3p21.3; Apoptosis; Cell cycle; Microarray

Indexed keywords

BONE MORPHOGENETIC PROTEIN 5; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 2; ENDOPEPTIDASE LA; PROTEIN H37; PROTEIN LUCA 15; RNA BINDING PROTEIN 5; STAT5 PROTEIN; STEROID RECEPTOR COACTIVATOR 3; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL FATE; CELL PROLIFERATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

EID: 33646837901     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.02.009     Document Type: Article

References (35)

1. Kok K., Naylor S.L., and Buys C.H.C.M. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 71 (1997) 27-92
2. Wistuba I.I., Behrens C., Virmani A.K., Mele G., Milchgrub S., Girard L., Fondon J.W., Garner H.R., McKay B., Latif F., Lerman M.I., Lam S., Gazdar A.F., and Minna J.D. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60 (2000) 1949-1960
3. Wei M.H., Latif F., Bader S., Kashuba V., Chen J.Y., Duh F.M., Sekido Y., Lee C.C., Geil L., Kuzmin I., Zabarovsky E., Klein G., Zbar B., Minna J.D., and Lerman M.I. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res. 56 (1996) 1487-1492
4. Timmer T., Terpstra P., van den Berg A., Veldhuis P.M.J.F., Ter Elst A., van der Veen A.Y., Kok K., Naylor S.L., and Buys C.H.C.M. An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers. Genomics 60 (1999) 238-240
5. Oh J.J., Grosshans D.R., Wong S.G., and Slamon D.J. Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. Nucleic Acids Res. 27 (1999) 4008-4017
6. Sutherland L.C., Rintala-Maki N.D., White R.D., and Morin C.D. RNA binding motif (RBM) proteins: a novel family of apoptosis modulators?. J. Cell. Biochem. 94 (2005) 5-24
7. Edamatsu H., Kaziro Y., and Itoh H. LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells. Genes Cells 5 (2000) 849-858
8. Oh J.J., West A.R., Fishbein M.C., and Slamon D.J. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Res. 62 (2002) 3207-3213
9. Mourtada-Maarabouni M., Sutherland L.C., Meredith J.M., and Williams G.T. Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5. Genes Cells 8 (2003) 109-119
10. Rintala-Maki N.D., and Sutherland L.C. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis 9 (2004) 475-484
11. Rintala-Maki N.D., Abrasonis V., Burd M., and Sutherland L.C. Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis. Cell Biochem. Funct. 22 (2004) 307-313
12. Mourtada-Maarabouni M., Sutherland L.C., and Williams G.T. Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways. Apoptosis 7 (2002) 421-432
13. Sutherland L.C., Edwards S.E., Cable H.C., Poirier G.G., Miller B.A., Cooper C.S., and Williams G.T. LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene 19 (2000) 3774-3781
14. Clark J., Edwards S., John M., Flohr P., Gordon T., Maillard K., Giddings I., Brown C., Bagherzadeh A., Campbell C., Shipley J., Wooster R., and Cooper C.S. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes Chromosomes Cancer 34 (2002) 104-114
15. Baskiewicz-Masiuk M., and Machalinski B. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. Eur. J. Haematol. 72 (2004) 420-429
16. Park M.Y., Ryu S.W., Kim K.D., Lim J.S., Lee Z.W., and Kim E. Fas-associated factor-1 mediates chemotherapeutic-induced apoptosis via death effector filament formation. Int. J. Cancer 115 (2005) 412-418
17. Golsteyn R.M. CDK1 and CDK2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle. Cancer Lett. 217 (2005) 129-138
18. Vishwanatha J.K., Salazar E., and Gopalakrishnan V.K. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 4 (2004) (Art. No. 8)
19. Lin Y.S., Khokhlatchev A., Figeys D., and Avruch J. Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis. J. Biol. Chem. 277 (2002) 47991-48001
20. Yamashita Y., Kajigaya S., Yoshida K., Ueno S., Ota J., Ohmine K., Ueda M., Miyazato A., Ohya K., Kitamura T., Ozawa K., and Mano H. Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase. J. Biol. Chem. 276 (2001) 39012-39020
21. Ranes-goldberg M.G., Hori T., Mohan-peterson S., and Spits H. Identification of human pre-T/NK cell-associated genes. J. Immunol. 151 (1993) 5810-5821
22. Carmeci C., Thompson D.A., Ring H.J.Z., Francke U., and Weigel R.J. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45 (1997) 607-617
23. Lin S.Y., and Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 (2003) 881-889
24. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., and Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 26 (2000) 435-439
25. Kumar A., Mandiyan V., Suzuki Y., Zhang C., Rice J., Tsai J., Artis D.R., Ibrahim P., and Bremer R. Crystal structures of proto-oncogene kinase pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma. J. Mol. Biol. 348 (2005) 183-193
26. Lin S.R., McLennan A.G., Ying K., Wang Z., Gu S.H., Jin H., Wu C.Q., Liu W.P., Yuan Y.Z., Tang R., Xie Y., and Mao Y.M. Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the ITPA gene. J. Biol. Chem. 276 (2001) 18695-18701
27. Henke R.T., Haddad B.R., Kim S.E., Rone J.D., Mani A., Jessup J.M., Wellstein A., Maitra A., and Riegel A.T. Overexpression of the nuclear receptor coactivator AIB1, (SRC-3) during progression of pancreatic adenocarcinoma. Clin. Cancer Res. 10 (2004) 6134-6142
28. Baskiewicz-Masiuk M., Masiuk M., and Machalinski B. The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines. Cell Proliferation 36 (2003) 265-278
29. Bia X.F., Ni X.G., Zhao P., Liu S.M., Wang H.X., Guo B., Zhou L.P., Liu F., Zhang J.S., Wang K., Xie Y.Q., Shao Y.F., and Zhao X.H. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 10 (2004) 1466-1470
30. Smitherman A.B., Mohler J.L., Maygarden S.J., and Ornstein D.K. Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J. Urol. 171 (2004) 916-920
31. Rothhammer T., Poser I., Soncin F., Bataille F., Moser M., and Bosserhoff A.K. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 65 (2005) 448-456
32. Zuzarte-Luis V., Montero J.A., Rodriguez-Leon J., Merino R., Rodriguez-Rey J.C., and Hurle J.M. A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev. Biol. 272 (2004) 39-52
33. Golden J.A., Bracilovic A., McFadden K.A., Beesley J.S., Rubenstein J.L.R., and Grinspan J.B. Ectopic bone morphogenetic proteins 5 and 4 in the chicken forebrain lead to cyclopia and holoprosencephaly. Proc. Nat. Acad. Sci. U. S. A. 96 (1999) 2439-2444
34. Drabkin H.A., West J.D., Hotfilder M., Heng Y.M., Erickson P., Calvo R., Dalmau J., Gemmill R.M., and Sablitzky F. DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene 18 (1999) 2589-2597
35. Uren A.G., Pakusch M., Hawkins C.J., Puls K.L., and Vaux D.L. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Nat. Acad. Sci. U. S. A. 93 (1996) 4974-4978